Cipriani G, Dolciotti C, Picchi L, Bonuccelli U. Alzheimer and his disease: a brief history. Neurol Sci. 2011;32:275–9.

Article  PubMed  Google Scholar 

Soria Lopez JA, González HM, Léger GC. Chapter 13 - Alzheimer’s disease. In: Dekosky ST, Asthana S, editors. Handbook of clinical neurology, vol 167. Elsevier; 2019. p. 231–55. https://doi.org/10.1016/B978-0-12-804766-8.00013-3.

Chapter  Google Scholar 

Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P. Intranasal drug delivery for treatment of Alzheimer’s disease. Drug Deliv Transl Res. 2021;11(2):411–25. https://doi.org/10.1007/s13346-021-00940-7.

Article  PubMed  Google Scholar 

Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, Aichour MTE, Akinyemi RO, Alahdab F, Asgedom SW, Awasthi A, Barker-Collo SL, Baune BT, Béjot Y, Belachew AB, Bennett DA, Biadgo B, Bijani A, Bin Sayeed MS, Brayne C, Carpenter DO, Carvalho F, Catalá-López F, Cerin E, Choi J-YJ, Dang AK, Degefa MG, Djalalinia S, Dubey M, Duken EE, Edvardsson D, Endres M, Eskandarieh S, Faro A, Farzadfar F, Fereshtehnejad S-M, Fernandes E, Filip I, Fischer F, Gebre AK, Geremew D, Ghasemi-Kasman M, Gnedovskaya EV, Gupta R, Hachinski V, Hagos TB, Hamidi S, Hankey GJ, Haro JM, Hay SI, Irvani SSN, Jha RP, Jonas JB, Kalani R, Karch A, Kasaeian A, Khader YS, Khalil IA, Khan EA, Khanna T, Khoja TAM, Khubchandani J, Kisa A, Kissimova-Skarbek K, Kivimäki M, Koyanagi A, Krohn KJ, Logroscino G, Lorkowski S, Majdan M, Malekzadeh R, März W, Massano J, Mengistu G, Meretoja A, Mohammadi M, Mohammadi-Khanaposhtani M, Mokdad AH, Mondello S, Moradi G, Nagel G, Naghavi M, Naik G, Nguyen LH, Nguyen TH, Nirayo YL, Nixon MR, Ofori-Asenso R, Ogbo FA, Olagunju AT, Owolabi MO, Panda-Jonas S, Passos VMdA, Pereira DM, Pinilla-Monsalve GD, Piradov MA, Pond CD, Poustchi H, Qorbani M, Radfar A, Reiner RC Jr, Robinson SR, Roshandel G, Rostami A, Russ TC, Sachdev PS, Safari H, Safiri S, Sahathevan R, Salimi Y, Satpathy M, Sawhney M, Saylan M, Sepanlou SG, Shafieesabet A, Shaikh MA, Sahraian MA, Shigematsu M, Shiri R, Shiue I, Silva JP, Smith M, Sobhani S, Stein DJ, Tabarés-Seisdedos R, Tovani-Palone MR, Tran BX, Tran TT, Tsegay AT, Ullah I, Venketasubramanian N, Vlassov V, Wang Y-P, Weiss J, Westerman R, Wijeratne T, Wyper GMA, Yano Y, Yimer EM, Yonemoto N, Yousefifard M, Zaidi Z, Zare Z, Vos T, Feigin VL, Murray CJL. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88–106. https://doi.org/10.1016/S1474-4422(18)30403-4.

Article  Google Scholar 

Schachter AS, Davis KL. Alzheimer’s disease. Dialogues in clinical neuroscience. 2000;2(2):91–100. https://doi.org/10.31887/DCNS.2000.2.2/asschachter.

Pardridge WM. Treatment of Alzheimer’s disease and blood-brain barrier drug delivery. Pharmaceuticals (Basel, Switzerland). 2020;13 (11). https://doi.org/10.3390/ph13110394.

Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci. 2001;6(1):66–77. https://doi.org/10.1016/S1359-0294(00)00090-X.

Article  CAS  Google Scholar 

Akhtar A, Andleeb A, Waris TS, Bazzar M, Moradi AR, Awan NR, Yar M. Neurodegenerative diseases and effective drug delivery: a review of challenges and novel therapeutics. J Control Release. 2021;330:1152–67. https://doi.org/10.1016/j.jconrel.2020.11.021.

Article  CAS  PubMed  Google Scholar 

Faiyaz M, Ganayee MA, Akhtar S, Krishnan S, Flora B, Dogra D, Jha NK, Chellappan DK, Negi P, Dua K, Kesari KK, Gupta PK. Nanomaterials in Alzheimer’s disease treatment: a comprehensive review. FBL. 2021;26(10):851–65. https://doi.org/10.52586/4992.

Article  CAS  PubMed  Google Scholar 

Agrawal M, Prathyusha E, Ahmed H, Dubey SK, Kesharwani P, Singhvi G, Naidu VGM, Alexander A. Biomaterials in treatment of Alzheimer’s disease. Neurochem Int. 2021;145:105008. https://doi.org/10.1016/j.neuint.2021.105008.

Article  CAS  PubMed  Google Scholar 

Thoe ES, Fauzi A, Tang YQ, Chamyuang S, Chia AYY. A review on advances of treatment modalities for Alzheimer’s disease. Life Sci. 2021;276:119129.

Article  Google Scholar 

Uchida Y, Kan H, Sakurai K, Oishi K, Matsukawa N. Contributions of blood–brain barrier imaging to neurovascular unit pathophysiology of Alzheimer’s disease and related dementias. Front Aging Neurosci. 2023;15:1111448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horie K, Salvadó G, Barthélemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease. Nat Med. 2023;29(8):1954–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parikh NH, Parikh PK, Rao HJ, Shah K, Dave BP, Prajapati BG (2024) Current trends and updates in the treatment of Alzheimer’s disease. In: Alzheimer’s disease and advanced drug delivery strategies. Elsevier, 373–390

Chapter  Google Scholar 

Spotorno N, Strandberg O, Vis G, Stomrud E, Nilsson M, Hansson O. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer’s disease. Brain. 2023;146(4):1602–14.

Article  PubMed  Google Scholar 

Prajapati V, Shinde S, Shrivastav P, Prajapati BG. New biologicals and biomaterials in the therapy of Alzheimer’s disease. In: Alzheimer’s disease and advanced drug delivery strategies. Elsevier; 2024. p. 93–114.

Chapter  Google Scholar 

Khodakiya A, Chaudhary S, Chaudhary A, Prajapati BG. Novel therapeutic approaches for targeting Alzheimer’s disease. In: Alzheimer’s disease and advanced drug delivery strategies. Elsevier; 2024. p. 297–318.

Chapter  Google Scholar 

Gawade A, Polshettiwar S, Hingalajia H, Prajapati BG, Singh A. Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer’s disease. In: Alzheimer’s disease and advanced drug delivery strategies. Elsevier. 2024;391–402.

Chapter  Google Scholar 

Khezri MR, Yousefi K, Esmaeili A, Ghasemnejad-Berenji M. The role of ERK1/2 pathway in the pathophysiology of Alzheimer’s disease: an overview and update on new developments. Cell Mol Neurobiol. 2023;43(1):177–91.

Article  CAS  PubMed  Google Scholar 

Chorawala MR, Shah AC, Pandya AJ, Kothari NR, Prajapati BG. Symptoms and conventional treatments of Alzheimer’s disease. Alzheimer’s disease and advanced drug delivery strategies. 2024;213–234.

Griffiths J, Grant SG. Synapse pathology in Alzheimer’s disease. Elsevier; 2023. p. 13–23.

Google Scholar 

Sirin S, Nigdelioglu Dolanbay S, Aslim B. The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19. J Neural Transm (Vienna). 2022;129(7):847–59. https://doi.org/10.1007/s00702-022-02499-0.

Article  CAS  PubMed  Google Scholar 

Sirkis DW, Bonham LW, Johnson TP, La Joie R. Yokoyama JSJMP. Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. 2022;27:2674–88.

CAS  Google Scholar 

Guzmán-Vélez E, Díez I, Schoemaker D, Pardilla-Delgado E, Vila-Castelar C, Fox-Fuller JT, Baena A, Sperling RA, Johnson KA, Lopera F, Sepulcre J, Quiroz YTJPotNAoSotUSoA. Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease. 2021;119.

Goyanes A, Fina F, Martorana A, Sedough D, Gaisford S, Basit AW. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int J Pharm. 2017;527(1):21–30. https://doi.org/10.1016/j.ijpharm.2017.05.021.

Article  CAS  PubMed  Google Scholar 

Wong KH, Riaz MK, Xie Y, Zhang X, Liu Q, Chen H, Bian Z, Chen X, Lu A, Yang Z. Review of current strategies for delivering Alzheimer’s disease drugs across the blood-brain barrier. Int J Mol Sci. 2019;20 (2). https://doi.org/10.3390/ijms20020381.

Poudel P, Park S. Recent advances in the treatment of Alzheimer’s disease using nanoparticle-based drug delivery systems. Pharmaceutics. 2022;14 (4). https://doi.org/10.3390/pharmaceutics14040835.

Bonilla C, Zurita M. Cell-based therapies for traumatic brain injury: therapeutic treatments and clinical trials. Biomedicines. 2021;9(6). https://doi.org/10.3390/biomedicines9060669.

Kassem LM, Ibrahim NA, Farhana SA. Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease? Journal of Nanotechnology. 2020;2020:8147080. https://doi.org/10.1155/2020/8147080.

Article  CAS  Google Scholar 

Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre randomised controlled trial. BMJ. 2000;321(7274):1445. https://doi.org/10.1136/bmj.321.7274.1445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Birks JS, Grimley Evans J.  Rivastigmine for Alzheimer’s disease. Cochrane Database Syst Rev. 2015;(4). https://doi.org/10.1002/14651858.CD001191.pub3.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. J Am Geriatr Soc. 2001;49(12):1590–9. https://doi.org/10.1111/j.1532-5415.2001.49266.x.

Article  CAS  PubMed  Google Scholar 

Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, Pandita-Gunawardena ND, Hogg F, Clare C, Damms J. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology. 2004;63(2):214–9. https://doi.org/10.1212/01.Wnl.0000129990.32253.7b.

Article  CAS  PubMed  Google Scholar 

Weisgraber HDP-LCKH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31: 445454.

Google Scholar 

Graham WV, Bonito-Oliva A, Sakmar TP. Update on Alzheimer’s disease therapy and prevention strategies. Annu Rev Med. 2017;68:413–30.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Zhang YI. Extraction of a source signal whose kurtosis value lies in a specific range. 2006;69 (7-9): 900-904.

Dhiman N, Bhattacharya A. Nardostachys jatamansi (D.Don) DC.-Challenges and opportunities of harnessing the untapped medicinal plant from the Himalayas. J Ethnopharmacol. 2020;246:112211. https://doi.org/10.1016/j.jep.2019.112211.

Article  CAS  PubMed  Google Scholar 

Pacheco SM, Soares MSP, Gutierres JM, Gerzson MFB, Carvalho FB, Azambuja JH, Schetinger MRC, Stefanello FM, Spanevello RM. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer’s type. J Nutr Biochem. 2018;56:193–204. https://doi.org/10.1016/j.jnutbio.2018.02.014.

Article  CAS  PubMed  Google Scholar 

Patil P, Thakur A, Sharma A, Flora SJS. Natural products and their derivatives as multifunctional ligands against Alzheimer’s disease. Drug Dev Res. 2020;81(2):165–83. https://doi.org/10.1002/ddr.21587.

Article  CAS  PubMed  Google Scholar 

Islam F, Khadija JF, Harun-Or-Rashid M, Rahaman MS, Nafady MH, Islam MR, Akter A, Emran TB, Wilairatana P, Mubarak MS. Bioactive compounds and their derivatives: an insight into prospective phytotherapeutic approach against Alzheimer’s disease. Oxid Med Cell Longev. 2022;2022:5100904. https://doi.org/10.1155/2022/5100904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh S, Supaweera N, Nwabor OF, Chaichompoo W, Suksamrarn A, Chittasupho C, Chunglok W. Poly (vinyl alcohol)-gelatin-sericin copolymerized film fortified with vesicle-entrapped demethoxycurcumin/bisdemethoxycurcumin for improved stability, antibacterial, anti-inflammatory, and skin tissue regeneration. Int J Biol Macromol. 2024;258:129071. https://doi.org/10.1016/j.ijbiomac.2023.129071.